Atropine Sulfate Injection (Olympia Pharmacy) – Sterility Concerns (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Brand
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Lot Codes / Batch Numbers
C5115 Exp 9/11/13
Products Sold
C5115 Exp 9/11/13
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL due to Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
This page aggregates publicly available data. Always confirm recall details directly with the U.S. Food and Drug Administration (FDA) before taking action.
View official FDA recall noticePage updated: Jan 7, 2026
Important Notice
This page displays information sourced from the U.S. Food and Drug Administration (FDA). IsMyProductRecalled.com aggregates public data for convenience and does not issue recalls. We are not affiliated with any government agency. Always verify recall information with the official source before taking action. This is not medical or legal advice.